{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T20:34:22Z","timestamp":1774384462410,"version":"3.50.1"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["National Natural Science Foundation of China"],"award-info":[{"award-number":["National Natural Science Foundation of China"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Henan Provincial Science and Technology Key Projects Program","award":["Henan Provincial Science and Technology Key Projects Program"],"award-info":[{"award-number":["Henan Provincial Science and Technology Key Projects Program"]}]},{"name":"Henan Provincial Medical Science and Technology Key Projects Program","award":["Henan Provincial Medical Science and Technology Key Projects Program"],"award-info":[{"award-number":["Henan Provincial Medical Science and Technology Key Projects Program"]}]},{"name":"Henan University graduate \u00abTalent Program\u00bb of Henan Province","award":["Henan University graduate \u00abTalent Program\u00bb of Henan Province"],"award-info":[{"award-number":["Henan University graduate \u00abTalent Program\u00bb of Henan Province"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-026-06152-x","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:07:03Z","timestamp":1773252423000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Redefining Parkinson\u2019s Disease management: the synergistic role of neurotrophic factors and mitochondria"],"prefix":"10.1007","volume":"83","author":[{"given":"Junkai","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zisen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangshu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3560-3392","authenticated-orcid":false,"given":"Jianshe","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"6152_CR1","doi-asserted-by":"crossref","unstructured":"1. Xu T, Dong W, Liu J, Yin P, Wang Z, Zhang L, Zhou M. Disease burden of Parkinson\u2019s disease in China and its provinces from 1990 to 2021: findings from the global burden of disease study 2021. Lancet Reg Health West Pac. 2024 May 8;46:101078.","DOI":"10.1016\/j.lanwpc.2024.101078"},{"issue":"10423","key":"6152_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, Tanner C (2024) The epidemiology of Parkinson\u2019s disease. Lancet 403(10423):283\u2013292. https:\/\/doi.org\/10.1016\/S0140-6736(23)01419-8","journal-title":"Lancet"},{"issue":"10291","key":"6152_CR3","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet 397(10291):2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet"},{"issue":"5","key":"6152_CR4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.32604\/biocell.2024.049130","volume":"48","author":"T Liu","year":"2024","unstructured":"Liu T, Hao Y, Zhao L (2024) Pathogenic genes associated with parkinson\u2019s disease: molecular mechanism overview. Biocell 48(5):707\u2013729","journal-title":"Biocell"},{"key":"6152_CR5","doi-asserted-by":"crossref","unstructured":"5. Morris HR, Spillantini MG, Sue CM, Williams-Gray CH. The pathogenesis of Parkinson\u2019s disease. Lancet. 2024 Jan 20;403(10423):293\u2013304.","DOI":"10.1016\/S0140-6736(23)01478-2"},{"issue":"8","key":"6152_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084148","volume":"23","author":"TW Liu","year":"2022","unstructured":"Liu TW, Chen CM, Chang KH (2022) Biomarker of neuroinflammation in Parkinson\u2019s Disease. Int J Mol Sci 23(8):4148. https:\/\/doi.org\/10.3390\/ijms23084148","journal-title":"Int J Mol Sci"},{"issue":"10","key":"6152_CR7","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s12264-025-01439-8","volume":"41","author":"T Liu","year":"2025","unstructured":"Liu T, Wu H, Wei J (2025) Bridging the gap: the neuro-immune axis as a key player in neurodegenerative disorders. Neurosci Bull 41(10):1867\u20131887","journal-title":"Neurosci Bull"},{"key":"6152_CR8","doi-asserted-by":"crossref","unstructured":"8. Matsuda W, Furuta T, Nakamura KC, Hioki H, Fujiyama F, Arai R, Kaneko T. Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci. 2009 Jan 14;29(2):444\u2009\u2212\u200953.","DOI":"10.1523\/JNEUROSCI.4029-08.2009"},{"key":"6152_CR9","doi-asserted-by":"crossref","unstructured":"9. Chen H, Li J, Huang Z, Fan X, Wang X, Chen X, Guo H, Liu H, Li S, Yu S, Li H, Huang X, Ma X, Deng X, Wang C, Liu Y. Dopaminergic system and neurons: Role in multiple neurological diseases. Neuropharmacology. 2024 Dec 1;260:110133.","DOI":"10.1016\/j.neuropharm.2024.110133"},{"key":"6152_CR10","doi-asserted-by":"crossref","unstructured":"10. Ebadpour N, Mahmoudi M, Kamal Kheder R, Abavisani M, Baridjavadi Z, Abdollahi N, Esmaeili SA. From mitochondrial dysfunction to neuroinflammation in Parkinson\u2019s disease: Pathogenesis and mitochondrial therapeutic approaches. Int Immunopharmacol. 2024 Dec 5;142(Pt A):113015.","DOI":"10.1016\/j.intimp.2024.113015"},{"key":"6152_CR11","doi-asserted-by":"crossref","unstructured":"11. Skaper SD. Neurotrophic Factors: An Overview. Methods Mol Biol. 2018;1727:1\u201317.","DOI":"10.1007\/978-1-4939-7571-6_1"},{"key":"6152_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.599543","volume":"12","author":"C Li","year":"2021","unstructured":"Li C, Sui C, Wang W, Yan J, Deng N, Du X, Cheng F, Ma X, Wang X, Wang Q (2021) Baicalin attenuates oxygen-glucose deprivation\/reoxygenation-induced injury by modulating the BDNF-TrkB\/PI3K\/Akt and MAPK\/Erk1\/2 signaling axes in neuron-astrocyte cocultures. Front Pharmacol 12:599543. https:\/\/doi.org\/10.3389\/fphar.2021.599543","journal-title":"Front Pharmacol"},{"issue":"1","key":"6152_CR13","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301664R","volume":"38","author":"J Fei","year":"2024","unstructured":"Fei J, Chen S, Song X, Liang Y, Duan K, Peng X, Li L (2024) Exogenous GDNF promotes peripheral facial nerve regeneration in rats through the PI3K\/AKT\/mTOR signaling pathway. FASEB J 38(1):e23340. https:\/\/doi.org\/10.1096\/fj.202301664R","journal-title":"FASEB J"},{"key":"6152_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2022.104846","volume":"129","author":"A Goyal","year":"2023","unstructured":"Goyal A, Agrawal A, Verma A, Dubey N (2023) The PI3K-AKT pathway: a plausible therapeutic target in Parkinson\u2019s disease. Exp Mol Pathol 129:104846","journal-title":"Exp Mol Pathol"},{"key":"6152_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.freeradbiomed.2024.02.023","volume":"216","author":"L Wang","year":"2024","unstructured":"Wang L, Tian S, Ruan S, Wei J, Wei S, Chen W, Hu H, Qin W, Li Y, Yuan H, Mao J, Xu Y, Xie J (2024) Neuroprotective effects of cordycepin on MPTP-induced Parkinson\u2019s disease mice via suppressing PI3K\/AKT\/mTOR and MAPK-mediated neuroinflammation. Free Radic Biol Med 216:60\u201377","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"6152_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18368","volume":"28","author":"NH Ali","year":"2024","unstructured":"Ali NH, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, AlAseeri AA, Alruwaili M, Saad HM, Batiha GE (2024) BDNF\/TrkB activators in Parkinson\u2019s disease: a new therapeutic strategy. J Cell Mol Med 28(10):e18368","journal-title":"J Cell Mol Med"},{"issue":"8","key":"6152_CR17","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s11064-023-03904-0","volume":"48","author":"S Moradi Vastegani","year":"2023","unstructured":"Moradi Vastegani S, Nasrolahi A, Ghaderi S, Belali R, Rashno M, Farzaneh M, Khoshnam SE (2023) Mitochondrial dysfunction and Parkinson\u2019s disease: pathogenesis and therapeutic strategies. Neurochem Res 48(8):2285\u20132308","journal-title":"Neurochem Res"},{"key":"6152_CR18","doi-asserted-by":"crossref","unstructured":"18. Ni A, Ernst C. Evidence That Substantia Nigra Pars Compacta Dopaminergic Neurons Are Selectively Vulnerable to Oxidative Stress Because They Are Highly Metabolically Active. Front Cell Neurosci. 2022 Mar 4;16:826193.","DOI":"10.3389\/fncel.2022.826193"},{"issue":"9","key":"6152_CR19","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/1873-3468.14298","volume":"596","author":"D Trigo","year":"2022","unstructured":"Trigo D, Avelar C, Fernandes M, S\u00e1 J, da Cruz E Silva O (2022) Mitochondria, energy, and metabolism in neuronal health and disease. FEBS Lett 596(9):1095\u20131110","journal-title":"FEBS Lett"},{"issue":"10","key":"6152_CR20","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s12264-022-00899-6","volume":"38","author":"J Zhang","year":"2022","unstructured":"Zhang J, Shen Q, Ma Y, Liu L, Jia W, Chen L, Xie J (2022) Calcium homeostasis in Parkinson\u2019s disease: from pathology to treatment. Neurosci Bull 38(10):1267\u20131270","journal-title":"Neurosci Bull"},{"key":"6152_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102077","volume":"91","author":"XS Ding","year":"2023","unstructured":"Ding XS, Gao L, Han Z, Eleuteri S, Shi W, Shen Y, Song ZY, Su M, Yang Q, Qu Y, Simon DK, Wang XL, Wang B (2023) Ferroptosis in Parkinson\u2019s disease: molecular mechanisms and therapeutic potential. Ageing Res Rev 91:102077","journal-title":"Ageing Res Rev"},{"issue":"8","key":"6152_CR22","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100201RR","volume":"35","author":"C Ducrot","year":"2021","unstructured":"Ducrot C, Bourque MJ, Delmas CVL, Racine AS, Guadarrama Bello D, Delignat-Lavaud B, Domenic Lycas M, Fallon A, Michaud-Tardif C, Burke Nanni S, Herborg F, Gether U, Nanci A, Takahashi H, Parent M, Trudeau LE (2021) Dopaminergic neurons establish a distinctive axonal arbor with a majority of non-synaptic terminals. FASEB J 35(8):e21791","journal-title":"FASEB J"},{"issue":"1","key":"6152_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41583-021-00535-8","volume":"23","author":"S Li","year":"2022","unstructured":"Li S, Sheng ZH (2022) Energy matters: presynaptic metabolism and the maintenance of synaptic transmission. Nat Rev Neurosci 23(1):4\u201322","journal-title":"Nat Rev Neurosci"},{"key":"6152_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1874205X01206010001","volume":"6","author":"A Anvret","year":"2012","unstructured":"Anvret A, Ran C, Westerlund M, Sydow O, Willows T, Olson L, Galter D, Belin AC (2012) Genetic screening of the mitochondrial Rho GTPases MIRO1 and MIRO2 in Parkinson\u2019s disease. Open Neurol J 6:1\u20135","journal-title":"Open Neurol J"},{"key":"6152_CR25","doi-asserted-by":"crossref","unstructured":"25. Wang B, Huang M, Shang D, Yan X, Zhao B, Zhang X. Mitochondrial Behavior in Axon Degeneration and Regeneration. Front Aging Neurosci. 2021 Mar 8;13:650038.","DOI":"10.3389\/fnagi.2021.650038"},{"key":"6152_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neures.2018.08.014","volume":"139","author":"S Kiryu-Seo","year":"2019","unstructured":"Kiryu-Seo S, Kiyama H (2019) Mitochondrial behavior during axon regeneration\/degeneration in vivo. Neurosci Res 139:42\u201347","journal-title":"Neurosci Res"},{"key":"6152_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ceca.2017.05.003","volume":"69","author":"S Marchi","year":"2018","unstructured":"Marchi S, Patergnani S, Missiroli S, Morciano G, Rimessi A, Wieckowski MR, Giorgi C, Pinton P (2018) Mitochondrial and endoplasmic reticulum calcium homeostasis and cell death. Cell Calcium 69:62\u201372","journal-title":"Cell Calcium"},{"issue":"19","key":"6152_CR28","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/febs.14607","volume":"285","author":"DJ Surmeier","year":"2018","unstructured":"Surmeier DJ (2018) Determinants of dopaminergic neuron loss in Parkinson\u2019s disease. FEBS J 285(19):3657\u20133668","journal-title":"FEBS J"},{"issue":"8","key":"6152_CR29","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1007\/s11011-021-00840-2","volume":"36","author":"A Pathania","year":"2021","unstructured":"Pathania A, Garg P, Sandhir R (2021) Impaired mitochondrial functions and energy metabolism in MPTP-induced Parkinson\u2019s disease: comparison of mice strains and dose regimens. Metab Brain Dis 36(8):2343\u20132357","journal-title":"Metab Brain Dis"},{"issue":"1","key":"6152_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4103\/1673-5374.286946","volume":"16","author":"HA Park","year":"2021","unstructured":"Park HA, Broman K, Jonas EA (2021) Oxidative stress battles neuronal Bcl-xL in a fight to the death. Neural Regen Res 16(1):12\u201315","journal-title":"Neural Regen Res"},{"issue":"6","key":"6152_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S1357-2725(98)00006-5","volume":"30","author":"HJ Brady","year":"1998","unstructured":"Brady HJ, Gil-G\u00f3mez G (1998) Bax. The pro-apoptotic Bcl-2 family member, Bax. Int J Biochem Cell Biol 30(6):647\u201350","journal-title":"Int J Biochem Cell Biol"},{"key":"6152_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2020.105704","volume":"121","author":"HA Kalpage","year":"2020","unstructured":"Kalpage HA, Wan J, Morse PT, Zurek MP, Turner AA, Khobeir A, Yazdi N, Hakim L, Liu J, Vaishnav A, Sanderson TH, Recanati MA, Grossman LI, Lee I, Edwards BFP, H\u00fcttemann M (2020) Cytochrome c phosphorylation: control of mitochondrial electron transport chain flux and apoptosis. Int J Biochem Cell Biol 121:105704","journal-title":"Int J Biochem Cell Biol"},{"issue":"12","key":"6152_CR33","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1080\/15548627.2019.1596494","volume":"15","author":"H Xian","year":"2019","unstructured":"Xian H, Liou YC (2019) Loss of MIEF1\/MiD51 confers susceptibility to BAX-mediated cell death and PINK1-PRKN-dependent mitophagy. Autophagy 15(12):2107\u20132125","journal-title":"Autophagy"},{"issue":"6","key":"6152_CR34","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1111\/j.1471-4159.2007.05115.x","volume":"104","author":"M Gomez-Lazaro","year":"2008","unstructured":"Gomez-Lazaro M, Galindo MF, Concannon CG, Segura MF, Fernandez-Gomez FJ, Llecha N, Comella JX, Prehn JH, Jordan J (2008) 6-hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK-mediated, p53-independent activation of Bax and PUMA. J Neurochem 104(6):1599\u2013612","journal-title":"J Neurochem"},{"issue":"11","key":"6152_CR35","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s10495-011-0627-8","volume":"16","author":"CK Oh","year":"2011","unstructured":"Oh CK, Han BS, Choi WS, Youdim MB, Oh YJ (2011) Translocation and oligomerization of Bax is regulated independently by activation of p38 MAPK and caspase-2 during MN9D dopaminergic neurodegeneration. Apoptosis 16(11):1087\u2013100","journal-title":"Apoptosis"},{"key":"6152_CR36","doi-asserted-by":"crossref","unstructured":"36. Vogler M, Braun Y, Smith VM, Westhoff MA, Pereira RS, Pieper NM, Anders M, Callens M, Vervliet T, Abbas M, Macip S, Schmid R, Bultynck G, Dyer MJ. The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy. Signal Transduct Target Ther. 2025 Mar 21;10(1):91.","DOI":"10.1038\/s41392-025-02176-0"},{"key":"6152_CR37","doi-asserted-by":"crossref","unstructured":"37. Chen YB, Aon MA, Hsu YT, Soane L, Teng X, McCaffery JM, Cheng WC, Qi B, Li H, Alavian KN, Dayhoff-Brannigan M, Zou S, Pineda FJ, O\u2019Rourke B, Ko YH, Pedersen PL, Kaczmarek LK, Jonas EA, Hardwick JM. Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential. J Cell Biol. 2011 Oct 17;195(2):263\u2009\u2212\u200976.","DOI":"10.1083\/jcb.201108059"},{"issue":"1","key":"6152_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1006\/nbdi.2002.0494","volume":"10","author":"A Hartmann","year":"2002","unstructured":"Hartmann A, Mouatt-Prigent A, Vila M, Abbas N, Perier C, Faucheux BA, Vyas S, Hirsch EC (2002) Increased expression and redistribution of the antiapoptotic molecule Bcl-xL in Parkinson\u2019s disease. Neurobiol Dis 10(1):28\u201332","journal-title":"Neurobiol Dis"},{"issue":"3","key":"6152_CR39","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1471-4159.2007.05028.x","volume":"104","author":"GP Dietz","year":"2008","unstructured":"Dietz GP, Stockhausen KV, Dietz B, Falkenburger BH, Valbuena P, Opazo F, Lingor P, Meuer K, Weishaupt JH, Schulz JB, B\u00e4hr M (2008) Membrane-permeable Bcl-xL prevents MPTP-induced dopaminergic neuronal loss in the substantia nigra. J Neurochem 104(3):757\u201365","journal-title":"J Neurochem"},{"key":"6152_CR40","doi-asserted-by":"crossref","unstructured":"40. Liu T, Kong X, Qiao J, Wei J. Decoding Parkinson\u2019s Disease: The interplay of cell death pathways, oxidative stress, and therapeutic innovations. Redox Biol. 2025 Jul 23;85:103787.","DOI":"10.1016\/j.redox.2025.103787"},{"key":"6152_CR41","doi-asserted-by":"crossref","unstructured":"41. Kim DY, Leem YH, Park JS, Park JE, Park JM, Kang JL, Kim HS. RIPK1 Regulates Microglial Activation in Lipopolysaccharide-Induced Neuroinflammation and MPTP-Induced Parkinson\u2019s Disease Mouse Models. Cells. 2023 Jan 26;12(3):417.","DOI":"10.3390\/cells12030417"},{"key":"6152_CR42","doi-asserted-by":"crossref","unstructured":"42. Xu X, Sun B, Zhao C. Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities. Neurobiol Dis. 2023 Oct 15;187:106314.","DOI":"10.1016\/j.nbd.2023.106314"},{"key":"6152_CR43","doi-asserted-by":"crossref","unstructured":"43. Kam TI, Mao X, Park H, Chou SC, Karuppagounder SS, Umanah GE, Yun SP, Brahmachari S, Panicker N, Chen R, Andrabi SA, Qi C, Poirier GG, Pletnikova O, Troncoso JC, Bekris LM, Leverenz JB, Pantelyat A, Ko HS, Rosenthal LS, Dawson TM, Dawson VL. Poly(ADP-ribose) drives pathologic \u03b1-synuclein neurodegeneration in Parkinson\u2019s disease. Science. 2018 Nov 2;362(6414):eaat8407.","DOI":"10.1126\/science.aat8407"},{"key":"6152_CR44","doi-asserted-by":"crossref","unstructured":"44. Barrientos SA, Martinez NW, Yoo S, Jara JS, Zamorano S, Hetz C, Twiss JL, Alvarez J, Court FA. Axonal degeneration is mediated by the mitochondrial permeability transition pore. J Neurosci. 2011 Jan 19;31(3):966\u2009\u2212\u200978.","DOI":"10.1523\/JNEUROSCI.4065-10.2011"},{"issue":"1","key":"6152_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0022-510X(90)90056-S","volume":"96","author":"Y Mizuno","year":"1990","unstructured":"Mizuno Y, Suzuki K, Ohta S (1990) Postmortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson\u2019s disease. J Neurol Sci 96(1):49\u201357","journal-title":"J Neurol Sci"},{"issue":"4","key":"6152_CR46","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s12035-022-03193-8","volume":"60","author":"MT Ibarra-Guti\u00e9rrez","year":"2023","unstructured":"Ibarra-Guti\u00e9rrez MT, Serrano-Garc\u00eda N, Orozco-Ibarra M (2023) Rotenone-induced model of Parkinson\u2019s disease: beyond mitochondrial complex I inhibition. Mol Neurobiol 60(4):1929\u20131948","journal-title":"Mol Neurobiol"},{"key":"6152_CR47","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-1-0716-1495-2_10","volume":"2322","author":"H Maegawa","year":"2021","unstructured":"Maegawa H, Niwa H (2021) Generation of mitochondrial toxin rodent models of Parkinson\u2019s disease using 6-OHDA, MPTP, and rotenone. Methods Mol Biol 2322:95\u2013110","journal-title":"Methods Mol Biol"},{"issue":"2","key":"6152_CR48","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41580-024-00785-1","volume":"26","author":"LC T\u00e1bara","year":"2025","unstructured":"T\u00e1bara LC, Segawa M, Prudent J (2025) Molecular mechanisms of mitochondrial dynamics. Nat Rev Mol Cell Biol 26(2):123\u2013146. https:\/\/doi.org\/10.1038\/s41580-024-00785-1","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6152_CR49","doi-asserted-by":"crossref","unstructured":"49. McCoy MK, Cookson MR. Mitochondrial quality control and dynamics in Parkinson\u2019s disease. Antioxid Redox Signal. 2012 May 1;16(9):869\u2009\u2212\u200982.","DOI":"10.1089\/ars.2011.4019"},{"key":"6152_CR50","doi-asserted-by":"crossref","unstructured":"50. Lim KL, Ng XH, Grace LG, Yao TP. Mitochondrial dynamics and Parkinson\u2019s disease: focus on parkin. Antioxid Redox Signal. 2012 May 1;16(9):935\u2009\u2212\u200949.","DOI":"10.1089\/ars.2011.4105"},{"issue":"17","key":"6152_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411235","volume":"12","author":"Y Xi","year":"2025","unstructured":"Xi Y, Tao K, Wen X, Feng D, Mai Z, Ding H, Mao H, Wang M, Yang Q, Xiang J, Zhang J, Wu S (2025) SIRT3-mediated deacetylation of DRP1K711 prevents mitochondrial dysfunction in Parkinson\u2019s disease. Adv Sci 12(17):e2411235","journal-title":"Adv Sci"},{"key":"6152_CR52","doi-asserted-by":"crossref","unstructured":"52. Fan RZ, Sportelli C, Lai Y, Salehe SS, Pinnell JR, Brown HJ, Richardson JR, Luo S, Tieu K. A partial Drp1 knockout improves autophagy flux independent of mitochondrial function. Mol Neurodegener. 2024 Mar 19;19(1):26.","DOI":"10.1186\/s13024-024-00708-w"},{"key":"6152_CR53","doi-asserted-by":"crossref","unstructured":"53. Roy M, Itoh K, Iijima M, Sesaki H. Parkin suppresses Drp1-independent mitochondrial division. Biochem Biophys Res Commun. 2016 Jul 1;475(3):283-8.","DOI":"10.1016\/j.bbrc.2016.05.038"},{"key":"6152_CR54","doi-asserted-by":"crossref","unstructured":"54. Chen M, Peng L, Gong P, Zheng X, Sun T, Zhang X, Huo J. Baicalein Mediates Mitochondrial Autophagy via miR-30b and the NIX\/BNIP3 Signaling Pathway in Parkinson\u2019s Disease. Biochem Res Int. 2021 Aug 18;2021:2319412.","DOI":"10.1155\/2021\/2319412"},{"key":"6152_CR55","doi-asserted-by":"crossref","unstructured":"55. Xu J, Deng Z, Shang S, Wang C, Han H. FUNDC1 collaborates with PINK1 in regulating mitochondrial Fission and compensating for PINK1 deficiency. Biochem Biophys Res Commun. 2023 Dec 20;687:149210.","DOI":"10.1016\/j.bbrc.2023.149210"},{"issue":"6","key":"6152_CR56","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13031","volume":"18","author":"BG Trist","year":"2019","unstructured":"Trist BG, Hare DJ, Double KL (2019) Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease. Aging Cell 18(6):e13031","journal-title":"Aging Cell"},{"key":"6152_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2022.113091","volume":"164","author":"T Jin","year":"2022","unstructured":"Jin T, Zhang Y, Botchway BOA, Zhang J, Fan R, Zhang Y, Liu X (2022) Curcumin can improve Parkinson\u2019s disease via activating BDNF\/PI3k\/Akt signaling pathways. Food Chem Toxicol 164:113091","journal-title":"Food Chem Toxicol"},{"issue":"5","key":"6152_CR58","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/dneu.20765","volume":"70","author":"A Yoshii","year":"2010","unstructured":"Yoshii A, Constantine-Paton M (2010) Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev Neurobiol 70(5):304\u201322","journal-title":"Dev Neurobiol"},{"issue":"3","key":"6152_CR59","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10735-013-9562-z","volume":"45","author":"ME Fenner","year":"2014","unstructured":"Fenner ME, Achim CL, Fenner BM (2014) Expression of full-length and truncated trkB in human striatum and substantia nigra neurons: implications for Parkinson\u2019s disease. J Mol Histol 45(3):349\u201361","journal-title":"J Mol Histol"},{"key":"6152_CR60","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-3-642-45106-5_9","volume":"220","author":"B Lu","year":"2014","unstructured":"Lu B, Nagappan G, Lu Y (2014) BDNF and synaptic plasticity, cognitive function, and dysfunction. Handb Exp Pharmacol 220:223\u201350","journal-title":"Handb Exp Pharmacol"},{"key":"6152_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156477","volume":"174","author":"M Dadkhah","year":"2024","unstructured":"Dadkhah M, Baziar M, Rezaei N (2024) The regulatory role of BDNF in neuroimmune axis function and neuroinflammation induced by chronic stress: a new therapeutic strategies for neurodegenerative disorders. Cytokine 174:156477","journal-title":"Cytokine"},{"key":"6152_CR62","doi-asserted-by":"crossref","unstructured":"62. Bondarenko O, Saarma M. Neurotrophic Factors in Parkinson\u2019s Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain. Front Cell Neurosci. 2021 Jun 2;15:682597.","DOI":"10.3389\/fncel.2021.682597"},{"key":"6152_CR63","doi-asserted-by":"crossref","unstructured":"63. Afarid M, Torabi-Nami M, Zare B. Neuroprotective and restorative effects of the brain-derived neurotrophic factor in retinal diseases. J Neurol Sci. 2016 Apr 15;363:43\u201350.","DOI":"10.1016\/j.jns.2016.02.024"},{"issue":"1","key":"6152_CR64","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00441-020-03269-8","volume":"382","author":"DM Gash","year":"2020","unstructured":"Gash DM, Gerhardt GA, Bradley LH, Wagner R, Slevin JT (2020) GDNF clinical trials for Parkinson\u2019s disease: a critical human dimension. Cell Tissue Res 382(1):65\u201370","journal-title":"Cell Tissue Res"},{"issue":"31","key":"6152_CR65","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.2174\/0929867325666180313101536","volume":"25","author":"RN Ferreira","year":"2018","unstructured":"Ferreira RN, de Miranda AS, Rocha NP, Simoes E Silva AC, Teixeira AL, da Silva Camargos ER (2018) Neurotrophic factors in Parkinson\u2019s disease: what have we learned from pre-clinical and clinical studies? Curr Med Chem 25(31):3682\u20133702","journal-title":"Curr Med Chem"},{"issue":"2","key":"6152_CR66","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ana.24436","volume":"78","author":"C Warren Olanow","year":"2015","unstructured":"Warren Olanow C, Bartus RT, Baumann TL, Factor S, Boulis N, Stacy M, Turner DA, Marks W, Larson P, Starr PA, Jankovic J, Simpson R, Watts R, Guthrie B, Poston K, Henderson JM, Stern M, Baltuch G, Goetz CG, Herzog C, Kordower JH, Alterman R, Lozano AM, Lang AE (2015) Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: a double-blind, randomized, controlled trial. Ann Neurol 78(2):248\u201357","journal-title":"Ann Neurol"},{"issue":"1","key":"6152_CR67","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00441-020-03262-1","volume":"382","author":"K Kawai","year":"2020","unstructured":"Kawai K, Takahashi M (2020) Intracellular RET signaling pathways activated by GDNF. Cell Tissue Res 382(1):113\u2013123","journal-title":"Cell Tissue Res"},{"key":"6152_CR68","doi-asserted-by":"crossref","unstructured":"68. Demir IE, Wang K, Tieftrunk E, Giese NA, Xing B, Friess H, Kehl T, Ceyhan GO. Neuronal plasticity in chronic pancreatitis is mediated via the neurturin\/GFR\u03b12 axis. Am J Physiol Gastrointest Liver Physiol. 2012 Nov 1;303(9):G1017-28.","DOI":"10.1152\/ajpgi.00517.2011"},{"issue":"12","key":"6152_CR69","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1016\/j.bbamcr.2013.07.004","volume":"1833","author":"L Zhou","year":"2013","unstructured":"Zhou L, Too HP (2013) GDNF family ligand dependent STAT3 activation is mediated by specific alternatively spliced isoforms of GFR\u03b12 and RET. Biochim Biophys Acta 1833(12):2789\u20132802","journal-title":"Biochim Biophys Acta"},{"key":"6152_CR70","doi-asserted-by":"crossref","unstructured":"70. Abu Shelbayeh O, Arroum T, Morris S, Busch KB. PGC-1\u03b1 Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response. Antioxidants (Basel). 2023 May 10;12(5):1075.","DOI":"10.3390\/antiox12051075"},{"key":"6152_CR71","doi-asserted-by":"crossref","unstructured":"71. Chengcheng M, Panpan A, Yalong Y, Mingyu S, Wei X, Jing C, Chuanxi T. GDNF improves the cognitive ability of PD mice by promoting glycosylation and membrane distribution of DAT. Sci Rep. 2024 Aug 1;14(1):17845.","DOI":"10.1038\/s41598-024-68609-y"},{"key":"6152_CR72","doi-asserted-by":"crossref","unstructured":"72. Grondin R, Littrell OM, Zhang Z, Ai Y, Huettl P, Pomerleau F, Quintero JE, Andersen AH, Stenslik MJ, Bradley LH, Lemmon J, O\u2019Neill MJ, Gash DM, Gerhardt GA. GDNF revisited: A novel mammalian cell-derived variant form of GDNF increases dopamine turnover and improves brain biodistribution. Neuropharmacology. 2019 Mar 15;147:28\u201336.","DOI":"10.1016\/j.neuropharm.2018.05.014"},{"key":"6152_CR73","doi-asserted-by":"crossref","unstructured":"73. Kumar A, Kopra J, Varendi K, Porokuokka LL, Panhelainen A, Kuure S, Marshall P, Karalija N, H\u00e4rma MA, Vilenius C, Lillev\u00e4li K, Tekko T, Mijatovic J, Pulkkinen N, Jakobson M, Jakobson M, Ola R, Palm E, Lindahl M, Str\u00f6mberg I, V\u00f5ikar V, Piepponen TP, Saarma M, Andressoo JO. Correction: GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function. PLoS Genet. 2016 Jan 11;12(1):e1005808.","DOI":"10.1371\/journal.pgen.1005808"},{"key":"6152_CR74","doi-asserted-by":"crossref","unstructured":"74. Kopra JJ, Panhelainen A, Af Bjerk\u00e9n S, Porokuokka LL, Varendi K, Olfat S, Montonen H, Piepponen TP, Saarma M, Andressoo JO. Dampened Amphetamine-Stimulated Behavior and Altered Dopamine Transporter Function in the Absence of Brain GDNF. J Neurosci. 2017 Feb 8;37(6):1581\u20131590.","DOI":"10.1523\/JNEUROSCI.1673-16.2016"},{"key":"6152_CR75","doi-asserted-by":"crossref","unstructured":"75. Carballo-Molina OA, Kolberg-Edelbrock AN, Alvarez-Saavedra M, \u00c1lvarez Z, Fyrner T, Perez-Rosello T, Syrgiannis Z, Chin SM, Takata N, Strong M, Palmer LC, James Surmeier D, Stupp SI. Supramolecular nanostructure mimics GDNF trophic effects in vitro on human dopaminergic neurons. NPJ Regen Med. 2025 Aug 8;10(1):37.","DOI":"10.1038\/s41536-025-00424-z"},{"issue":"2","key":"6152_CR76","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1006\/exnr.1999.7296","volume":"161","author":"C Rosenblad","year":"2000","unstructured":"Rosenblad C, Kirik D, Bj\u00f6rklund A (2000) Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model. Exp Neurol 161(2):503\u201316","journal-title":"Exp Neurol"},{"issue":"5","key":"6152_CR77","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s43440-020-00120-3","volume":"72","author":"P Chmielarz","year":"2020","unstructured":"Chmielarz P, Saarma M (2020) Neurotrophic factors for disease-modifying treatments of Parkinson\u2019s disease: gaps between basic science and clinical studies. Pharmacol Rep 72(5):1195\u20131217","journal-title":"Pharmacol Rep"},{"issue":"1","key":"6152_CR78","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00441-020-03227-4","volume":"382","author":"AK Mahato","year":"2020","unstructured":"Mahato AK, Sidorova YA (2020) Glial cell line-derived neurotrophic factors (GFLs) and small molecules targeting RET receptor for the treatment of pain and Parkinson\u2019s disease. Cell Tissue Res 382(1):147\u2013160","journal-title":"Cell Tissue Res"},{"key":"6152_CR79","doi-asserted-by":"crossref","unstructured":"79. Lindholm P, Voutilainen MH, Laur\u00e9n J, Per\u00e4nen J, Lepp\u00e4nen VM, Andressoo JO, Lindahl M, Janhunen S, Kalkkinen N, Timmusk T, Tuominen RK, Saarma M. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. Nature. 2007 Jul 5;448(7149):73\u2009\u2212\u20097.","DOI":"10.1038\/nature05957"},{"issue":"2","key":"6152_CR80","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1385\/JMN:20:2:173","volume":"20","author":"P Petrova","year":"2003","unstructured":"Petrova P, Raibekas A, Pevsner J, Vigo N, Anafi M, Moore MK, Peaire AE, Shridhar V, Smith DI, Kelly J, Durocher Y, Commissiong JW (2003) MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons. J Mol Neurosci 20(2):173\u201388","journal-title":"J Mol Neurosci"},{"key":"6152_CR81","doi-asserted-by":"publisher","DOI":"10.1101\/2024.12.17.628889","author":"V Kovaleva","year":"2024","unstructured":"Kovaleva V, Shpironok O, Yu L, Ivanova L, Fudo S, Happonen L, Toots U, Ustav M, Kajander T, Karelson M, Saarma M (2024) CDNF rescues human iPSCs-derived dopamine neurons through direct binding to unfolded protein response sensors PERK and IRE1\u03b1. bioRxiv. https:\/\/doi.org\/10.1101\/2024.12.17.628889","journal-title":"bioRxiv"},{"issue":"3","key":"6152_CR82","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/s41380-021-01394-6","volume":"27","author":"P Lindholm","year":"2022","unstructured":"Lindholm P, Saarma M (2022) Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism. Mol Psychiatry 27(3):1310\u20131321. https:\/\/doi.org\/10.1038\/s41380-021-01394-6","journal-title":"Mol Psychiatry"},{"issue":"1","key":"6152_CR83","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.expneurol.2010.12.013","volume":"228","author":"MH Voutilainen","year":"2011","unstructured":"Voutilainen MH, B\u00e4ck S, Per\u00e4nen J, Lindholm P, Raasmaja A, M\u00e4nnist\u00f6 PT, Saarma M, Tuominen RK (2011) Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson\u2019s disease. Exp Neurol 228(1):99\u2013108","journal-title":"Exp Neurol"},{"key":"6152_CR84","doi-asserted-by":"crossref","unstructured":"84. Voutilainen MH, B\u00e4ck S, P\u00f6rsti E, Toppinen L, Lindgren L, Lindholm P, Per\u00e4nen J, Saarma M, Tuominen RK. Mesencephalic astrocyte-derived neurotrophic factor is neurorestorative in rat model of Parkinson\u2019s disease. J Neurosci. 2009 Jul 29;29(30):9651-9.","DOI":"10.1523\/JNEUROSCI.0833-09.2009"},{"key":"6152_CR85","doi-asserted-by":"crossref","unstructured":"85. Voutilainen MH, De Lorenzo F, Stepanova P, B\u00e4ck S, Yu LY, Lindholm P, P\u00f6rsti E, Saarma M, M\u00e4nnist\u00f6 PT, Tuominen RK. Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action. eNeuro. 2017 Mar 13;4(1):ENEURO.0117-16.2017.","DOI":"10.1523\/ENEURO.0117-16.2017"},{"issue":"7","key":"6152_CR86","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/mds.29426","volume":"38","author":"HJ Huttunen","year":"2023","unstructured":"Huttunen HJ, Booms S, Sj\u00f6gren M, Kerstens V, Johansson J, Holmn\u00e4s R, Koskinen J, Kulesskaya N, Fazio P, Woolley M, Brady A, Williams J, Johnson D, Dailami N, Gray W, Levo R, Saarma M, Halldin C, Marjamaa J, Resendiz-Nieves J, Grubor I, Lind G, Eerola-Rautio J, Mertsalmi T, Andr\u00e9asson M, Paul G, Rinne J, Kivisaari R, Bjartmarz H, Almqvist P, Varrone A, Scheperjans F, Widner H, Svenningsson P (2023) Intraputamenal cerebral dopamine neurotrophic factor in Parkinson\u2019s disease: a randomized, double-blind, multicenter phase 1 trial. Mov Disord 38(7):1209\u20131222. https:\/\/doi.org\/10.1002\/mds.29426","journal-title":"Mov Disord"},{"key":"6152_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2023.114435","volume":"366","author":"EA Kasanga","year":"2023","unstructured":"Kasanga EA, Han Y, Navarrete W, McManus R, Shifflet MK, Parry C, Barahona A, Manfredsson FP, Nejtek VA, Richardson JR, Salvatore MF (2023) Differential expression of RET and GDNF family receptor, GFR-\u03b11, between striatum and substantia nigra following nigrostriatal lesion: a case for diminished GDNF-signaling. Exp Neurol 366:114435","journal-title":"Exp Neurol"},{"key":"6152_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2025.102516","volume":"111","author":"MN Khan","year":"2025","unstructured":"Khan MN, Choudhary D, Mehan S, Khan Z, Gupta GD, Narula AS (2025) Molecular mechanisms of GDNF\/GFRA1\/RET and PI3K\/AKT\/ERK signaling interplay in neuroprotection: therapeutic strategies for treating neurological disorders. Neuropeptides 111:102516","journal-title":"Neuropeptides"},{"key":"6152_CR89","doi-asserted-by":"crossref","unstructured":"89. Wang Y, Liang J, Xu B, Yang J, Wu Z, Cheng L. TrkB\/BDNF signaling pathway and its small molecular agonists in CNS injury. Life Sci. 2024 Jan 1;336:122282.","DOI":"10.1016\/j.lfs.2023.122282"},{"key":"6152_CR90","doi-asserted-by":"crossref","unstructured":"90. Jin W. Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson\u2019s Disease. J Clin Med. 2020 Jan 17;9(1):257.","DOI":"10.3390\/jcm9010257"},{"issue":"7","key":"6152_CR91","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1007\/s12035-023-03832-8","volume":"61","author":"Y Wu","year":"2024","unstructured":"Wu Y, Zhu Z, Lan T, Li S, Li Y, Wang C, Feng Y, Mao X, Yu S (2024) Levomilnacipran improves lipopolysaccharide-induced dysregulation of synaptic plasticity and depression-like behaviors via activating BDNF\/TrkB mediated PI3K\/Akt\/mTOR signaling pathway. Mol Neurobiol 61(7):4102\u20134115","journal-title":"Mol Neurobiol"},{"key":"6152_CR92","doi-asserted-by":"crossref","unstructured":"93. Majeed Y, Halabi N, Madani AY, Engelke R, Bhagwat AM, Abdesselem H, Agha MV, Vakayil M, Courjaret R, Goswami N, Hamidane HB, Elrayess MA, Rafii A, Graumann J, Schmidt F, Mazloum NA. SIRT1 promotes lipid metabolism and mitochondrial biogenesis in adipocytes and coordinates adipogenesis by targeting key enzymatic pathways. Sci Rep. 2021 Apr 14;11(1):8177.","DOI":"10.1038\/s41598-021-87759-x"},{"key":"6152_CR93","doi-asserted-by":"crossref","unstructured":"94. Bi X, Fang J, Jin X, Thirupathi A. The interplay between BDNF and PGC-1 alpha in maintaining brain health: role of exercise. Front Endocrinol (Lausanne). 2024 Aug 22;15:1433750.","DOI":"10.3389\/fendo.2024.1433750"},{"key":"6152_CR94","doi-asserted-by":"crossref","unstructured":"95. Moya-Alvarado G, Tiburcio-Felix R, Ib\u00e1\u00f1ez MR, Aguirre-Soto AA, Guerra MV, Wu C, Mobley WC, Perlson E, Bronfman FC. BDNF\/TrkB signaling endosomes in axons coordinate CREB\/mTOR activation and protein synthesis in the cell body to induce dendritic growth in cortical neurons. Elife. 2023 Feb 24;12:e77455.","DOI":"10.7554\/eLife.77455"},{"key":"6152_CR95","doi-asserted-by":"crossref","unstructured":"96. Singh R, Zahra W, Singh SS, Birla H, Rathore AS, Keshri PK, Dilnashin H, Singh S, Singh SP. Oleuropein confers neuroprotection against rotenone-induced model of Parkinson\u2019s disease via BDNF\/CREB\/Akt pathway. Sci Rep. 2023 Feb 11;13(1):2452.","DOI":"10.1038\/s41598-023-29287-4"},{"key":"6152_CR96","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.nbd.2016.01.002","volume":"88","author":"P Barroso-Chinea","year":"2016","unstructured":"Barroso-Chinea P, Cruz-Muros I, Afonso-Oramas D, Castro-Hern\u00e1ndez J, Salas-Hern\u00e1ndez J, Chtarto A, Luis-Ravelo D, Humbert-Claude M, Tenenbaum L, Gonz\u00e1lez-Hern\u00e1ndez T (2016) Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system. Neurobiol Dis 88:44\u201354","journal-title":"Neurobiol Dis"},{"issue":"7","key":"6152_CR97","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.psyneuen.2011.12.003","volume":"37","author":"W Liu","year":"2012","unstructured":"Liu W, Zhou C (2012) Corticosterone reduces brain mitochondrial function and expression of mitofusin, BDNF in depression-like rodents regardless of exercise preconditioning. Psychoneuroendocrinology 37(7):1057\u201370","journal-title":"Psychoneuroendocrinology"},{"key":"6152_CR98","doi-asserted-by":"crossref","unstructured":"99. Lapchak PA, Araujo DM, Hilt DC, Sheng J, Jiao S. Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson\u2019s disease. Brain Res. 1997 Nov 28;777(1\u20132):153\u2009\u2212\u200960.","DOI":"10.1016\/S0006-8993(97)01100-1"},{"key":"6152_CR99","doi-asserted-by":"crossref","unstructured":"100. Kreymerman A, Weinstein JE, Vadgama N, Shah SH, Nahmou MM, Belle KC, Ji MH, Xia X, Faust A, Van Der Merwe Y, Buickians DN, Cho IJ, Huynh SK, Verma S, Russano K, Jin XL, Karakikes I, Steketee MB, Goldberg JL. Light-evoked activity and BDNF regulate mitochondrial dynamics and mitochondrial localized translation in CNS axons. iScience. 2025 Sep 15;28(10):113563.","DOI":"10.1016\/j.isci.2025.113563"},{"key":"6152_CR100","doi-asserted-by":"crossref","unstructured":"101. Jin W. Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson\u2019s Disease. J Clin Med. 2020 Jan 17;9(1):257.","DOI":"10.3390\/jcm9010257"},{"key":"6152_CR101","doi-asserted-by":"crossref","unstructured":"102. Bj\u00f6rklund A, Kirik D, Rosenblad C, Georgievska B, Lundberg C, Mandel RJ. Towards a neuroprotective gene therapy for Parkinson\u2019s disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model. Brain Res. 2000 Dec 15;886(1\u20132):82\u201398.","DOI":"10.1016\/S0006-8993(00)02915-2"},{"key":"6152_CR102","doi-asserted-by":"crossref","unstructured":"103. Ferrari LF, Chum A, Bogen O, Reichling DB, Levine JD. Role of Drp1, a key mitochondrial fission protein, in neuropathic pain. J Neurosci. 2011 Aug 3;31(31):11404-10.","DOI":"10.1523\/JNEUROSCI.2223-11.2011"},{"key":"6152_CR103","doi-asserted-by":"crossref","unstructured":"104. Rambold AS, Kostelecky B, Elia N, Lippincott-Schwartz J. Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation. Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10190-5.","DOI":"10.1073\/pnas.1107402108"},{"key":"6152_CR104","doi-asserted-by":"crossref","unstructured":"105. Iwata R, Casimir P, Erkol E, Boubakar L, Planque M, Gallego L\u00f3pez IM, Ditkowska M, Gaspariunaite V, Beckers S, Remans D, Vints K, Vandekeere A, Poovathingal S, Bird M, Vlaeminck I, Creemers E, Wierda K, Corthout N, Vermeersch P, Carpentier S, Davie K, Mazzone M, Gounko NV, Aerts S, Ghesqui\u00e8re B, Fendt SM, Vanderhaeghen P. Mitochondria metabolism sets the species-specific tempo of neuronal development. Science. 2023 Feb 10;379(6632):eabn4705.","DOI":"10.1126\/science.abn4705"},{"key":"6152_CR105","doi-asserted-by":"crossref","unstructured":"106. Khidr HY, Hassan NF, Abdelrahman SS, El-Ansary MR, El-Yamany MF, Rabie MA. Formoterol attenuated mitochondrial dysfunction in rotenone-induced Parkinson\u2019s disease in a rat model: Role of PINK-1\/PARKIN and PI3K\/Akt\/CREB\/BDNF\/TrKB axis. Int Immunopharmacol. 2023 Dec;125(Pt B):111207.","DOI":"10.1016\/j.intimp.2023.111207"},{"issue":"12","key":"6152_CR106","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70147","volume":"30","author":"D Wang","year":"2024","unstructured":"Wang D, Wei SN, Zhang L, Lang ZC, Wang SN, Cheng B, Lu Y, Wang X, Wang W, Li FS, Zhang H (2024) Impaired basal forebrain cholinergic neuron GDNF signaling contributes to perioperative sleep deprivation-induced chronicity of postsurgical pain in mice through regulating cholinergic neuronal activity, apoptosis, and autophagy. CNS Neurosci Ther 30(12):e70147","journal-title":"CNS Neurosci Ther"},{"key":"6152_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2022.106359","volume":"155","author":"Z Mai","year":"2023","unstructured":"Mai Z, Sun H, Yang F, Du M, Cheng X, Chen H, Sun B, Wen J, Wang X, Chen T (2023) Bad is essential for Bcl-xL-enhanced Bax shuttling between mitochondria and cytosol. Int J Biochem Cell Biol 155:106359","journal-title":"Int J Biochem Cell Biol"},{"key":"6152_CR108","doi-asserted-by":"crossref","unstructured":"109. Eberhardt O, Coelln RV, Kugler S, Lindenau J, Rathke-Hartlieb S, Gerhardt E, Haid S, Isenmann S, Gravel C, Srinivasan A, Bahr M, Weller M, Dichgans J, Schulz JB. Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease. J Neurosci. 2000 Dec 15;20(24):9126-34.","DOI":"10.1523\/JNEUROSCI.20-24-09126.2000"},{"key":"6152_CR109","doi-asserted-by":"crossref","unstructured":"110. Szewczyk A, Bednarczyk P, Kulawiak B, \u017bochowska M, Kalenik B, Lewandowska J, Pytlak K, Ga\u0142ecka S, Wrzosek A, Koprowski P. Mitochondrial potassium channels: New properties and functions. Biochim Biophys Acta Bioenerg. 2025 Apr 1;1866(2):149546.","DOI":"10.1016\/j.bbabio.2025.149546"},{"key":"6152_CR110","doi-asserted-by":"crossref","unstructured":"111. Jaudon F, Albini M, Ferroni S, Benfenati F, Cesca F. A developmental stage- and Kidins220-dependent switch in astrocyte responsiveness to brain-derived neurotrophic factor. J Cell Sci. 2021 Aug 15;134(16):jcs258419.","DOI":"10.1242\/jcs.258419"},{"key":"6152_CR111","doi-asserted-by":"crossref","unstructured":"112. Zhou W, Hu G, He J, Wang T, Zuo Y, Cao Y, Zheng Q, Tu J, Ma J, Cai R, Chen Y, Fan Q, Dong B, Tan H, Wang Q, Xue W, Cheng J. SENP1-Sirt3 signaling promotes \u03b1-ketoglutarate production during M2 macrophage polarization. Cell Rep. 2022 Apr 12;39(2):110660.","DOI":"10.1016\/j.celrep.2022.110660"},{"issue":"8","key":"6152_CR112","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","volume":"11","author":"L Han","year":"2021","unstructured":"Han L, Jiang C (2021) Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies. Acta Pharm Sin B 11(8):2306\u20132325","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"6152_CR113","first-page":"252","volume":"6","author":"A Misra","year":"2003","unstructured":"Misra A, Ganesh S, Shahiwala A, Shah SP (2003) Drug delivery to the central nervous system: a review. J Pharm Pharm Sci 6(2):252\u201373","journal-title":"J Pharm Pharm Sci"},{"key":"6152_CR114","doi-asserted-by":"crossref","unstructured":"115. Whone A, Luz M, Boca M, Woolley M, Mooney L, Dharia S, Broadfoot J, Cronin D, Schroers C, Barua NU, Longpre L, Barclay CL, Boiko C, Johnson GA, Fibiger HC, Harrison R, Lewis O, Pritchard G, Howell M, Irving C, Johnson D, Kinch S, Marshall C, Lawrence AD, Blinder S, Sossi V, Stoessl AJ, Skinner P, Mohr E, Gill SS. Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson\u2019s disease. Brain. 2019 Mar 1;142(3):512\u2013525.","DOI":"10.1093\/brain\/awz023"},{"issue":"7","key":"6152_CR115","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/mds.30193","volume":"40","author":"AD Van Laar","year":"2025","unstructured":"Van Laar AD, Christine CW, Phielipp N, Larson PS, Elder JB, Merola A, San Sebastian W, Fiandaca MS, Kells AP, Wisniewski ME, Bankiewicz KS (2025) Intraputaminal delivery of adeno-associated virus serotype 2-glial cell line-derived neurotrophic factor in mild or moderate Parkinson\u2019s disease. Mov Disord 40(7):1297\u20131306","journal-title":"Mov Disord"},{"issue":"5","key":"6152_CR116","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","volume":"20","author":"GC Terstappen","year":"2021","unstructured":"Terstappen GC, Meyer AH, Bell RD, Zhang W (2021) Strategies for delivering therapeutics across the blood-brain barrier. Nat Rev Drug Discov 20(5):362\u2013383","journal-title":"Nat Rev Drug Discov"},{"key":"6152_CR117","doi-asserted-by":"crossref","unstructured":"118. Wang JH, Gessler DJ, Zhan W, Gallagher TL, Gao G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct Target Ther. 2024 Apr 3;9(1):78.","DOI":"10.1038\/s41392-024-01780-w"},{"key":"6152_CR118","doi-asserted-by":"crossref","unstructured":"119. Brown AJ, James DC. Constructing Strong Cell Type-Specific Promoters Through Informed Design. Methods Mol Biol. 2017;1651:131\u2013145.","DOI":"10.1007\/978-1-4939-7223-4_10"},{"issue":"2","key":"6152_CR119","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4103\/1673-5374.346466","volume":"18","author":"ZH Zhu","year":"2023","unstructured":"Zhu ZH, Jia F, Ahmed W, Zhang GL, Wang H, Lin CQ, Chen WH, Chen LK (2023) Neural stem cell-derived exosome as a nano-sized carrier for BDNF delivery to a rat model of ischemic stroke. Neural Regen Res 18(2):404\u2013409","journal-title":"Neural Regen Res"},{"key":"6152_CR120","doi-asserted-by":"crossref","unstructured":"121. Liu C, Chan CB, Ye K. 7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders. Transl Neurodegener. 2016 Jan 6;5:2.","DOI":"10.1186\/s40035-015-0048-7"},{"key":"6152_CR121","doi-asserted-by":"crossref","unstructured":"122. Sidorova YA, Saarma M. Small Molecules and Peptides Targeting Glial Cell Line-Derived Neurotrophic Factor Receptors for the Treatment of Neurodegeneration. Int J Mol Sci. 2020 Sep 8;21(18):6575.","DOI":"10.3390\/ijms21186575"},{"key":"6152_CR122","doi-asserted-by":"crossref","unstructured":"123. Ivanova L, Tammiku-Taul J, Sidorova Y, Saarma M, Karelson M. Small-Molecule Ligands as Potential GDNF Family Receptor Agonists. ACS Omega. 2018 Jan 31;3(1):1022\u20131030.","DOI":"10.1021\/acsomega.7b01932"},{"key":"6152_CR123","doi-asserted-by":"crossref","unstructured":"124. Bradley LH, Fuqua J, Richardson A, Turchan-Cholewo J, Ai Y, Kelps KA, Glass JD, He X, Zhang Z, Grondin R, Littrell OM, Huettl P, Pomerleau F, Gash DM, Gerhardt GA. Dopamine neuron stimulating actions of a GDNF propeptide. PLoS One. 2010 Mar 18;5(3):e9752.","DOI":"10.1371\/journal.pone.0009752"},{"key":"6152_CR124","doi-asserted-by":"crossref","unstructured":"125. Habib S, Singh M. Angiopep-2-Modified Nanoparticles for Brain-Directed Delivery of Therapeutics: A Review. Polymers (Basel). 2022 Feb 12;14(4):712.","DOI":"10.3390\/polym14040712"},{"key":"6152_CR125","doi-asserted-by":"crossref","unstructured":"126. Pakarinen E, Lindholm P. CDNF and MANF in the brain dopamine system and their potential as treatment for Parkinson\u2019s disease. Front Psychiatry. 2023 Jul 24;14:1188697.","DOI":"10.3389\/fpsyt.2023.1188697"},{"key":"6152_CR126","doi-asserted-by":"crossref","unstructured":"127. Yu LY, Viljakainen T, Beckett L, Nam J, Hyysalo A, L\u00fcningschr\u00f6r P, Albert K, Koppinen T, Hyv\u00e4rinen T, Tossavainen H, Hellman M, Airavaara M, Sendtner M, Permi P, Lindholm P, Saarma M, Voutilainen MH. Non-invasive peripheral delivery of CDNF fragment protects neurons in models of Parkinson\u2019s and ALS. BioXriv. 2025 Feb 10. doi: 10.1101\/2025.02.09.637291.","DOI":"10.1101\/2025.02.09.637291"},{"key":"6152_CR127","doi-asserted-by":"crossref","unstructured":"128. Gasca-Salas C, Fern\u00e1ndez-Rodr\u00edguez B, Pineda-Pardo JA, Rodr\u00edguez-Rojas R, Obeso I, Hern\u00e1ndez-Fern\u00e1ndez F, Del \u00c1lamo M, Mata D, Guida P, Ord\u00e1s-Bandera C, Montero-Roblas JI, Mart\u00ednez-Fern\u00e1ndez R, Foffani G, Rachmilevitch I, Obeso JA. Blood-brain barrier opening with focused ultrasound in Parkinson\u2019s disease dementia. Nat Commun. 2021 Feb 3;12(1):779.","DOI":"10.1038\/s41467-021-21022-9"},{"key":"6152_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114583","volume":"191","author":"CM Gorick","year":"2022","unstructured":"Gorick CM, Breza VR, Nowak KM, Cheng VWT, Fisher DG, Debski AC, Hoch MR, Demir ZEF, Tran NM, Schwartz MR, Sheybani ND, Price RJ (2022) Applications of focused ultrasound-mediated blood-brain barrier opening. Adv Drug Deliv Rev 191:114583","journal-title":"Adv Drug Deliv Rev"},{"key":"6152_CR129","doi-asserted-by":"crossref","unstructured":"130. Tacke C, DiStefano PS, Lindsay RM, Metzdorf K, Zagrebelsky M, Korte M. Actions of the TrkB Agonist Antibody ZEB85 in Regulating the Architecture and Synaptic Plasticity in Hippocampal Neurons. Front Mol Neurosci. 2022 Jun 30;15:945348.","DOI":"10.3389\/fnmol.2022.945348"},{"issue":"2","key":"6152_CR130","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4103\/1673-5374.177710","volume":"11","author":"AM Sullivan","year":"2016","unstructured":"Sullivan AM, O\u2019Keeffe GW (2016) Neurotrophic factor therapy for Parkinson\u2019s disease: past, present and future. Neural Regen Res 11(2):205\u20137","journal-title":"Neural Regen Res"},{"issue":"3","key":"6152_CR131","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3233\/JPD-202004","volume":"10","author":"RA Barker","year":"2020","unstructured":"Barker RA, Bj\u00f6rklund A, Gash DM, Whone A, Van Laar A, Kordower JH, Bankiewicz K, Kieburtz K, Saarma M, Booms S, Huttunen HJ, Kells AP, Fiandaca MS, Stoessl AJ, Eidelberg D, Federoff H, Voutilainen MH, Dexter DT, Eberling J, Brundin P, Isaacs L, Mursaleen L, Bresolin E, Carroll C, Coles A, Fiske B, Matthews H, Lungu C, Wyse RK, Stott S, Lang AE (2020) GDNF and Parkinson\u2019s disease: where next? A summary from a recent workshop. J Parkinsons Dis 10(3):875\u2013891","journal-title":"J Parkinsons Dis"},{"issue":"12","key":"6152_CR132","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1096\/fj.15-275404","volume":"29","author":"AO Oyewole","year":"2015","unstructured":"Oyewole AO, Birch-Machin MA (2015) Mitochondria-targeted antioxidants. FASEB J 29(12):4766\u201371","journal-title":"FASEB J"},{"issue":"5","key":"6152_CR133","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.biotechadv.2012.09.005","volume":"31","author":"J Gruber","year":"2013","unstructured":"Gruber J, Fong S, Chen CB, Yoong S, Pastorin G, Schaffer S, Cheah I, Halliwell B (2013) Mitochondria-targeted antioxidants and metabolic modulators as pharmacological interventions to slow ageing. Biotechnol Adv 31(5):563\u201392","journal-title":"Biotechnol Adv"},{"key":"6152_CR134","doi-asserted-by":"crossref","unstructured":"135. Snow BJ, Rolfe FL, Lockhart MM, Frampton CM, O\u2019Sullivan JD, Fung V, Smith RA, Murphy MP, Taylor KM; Protect Study Group. A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson\u2019s disease. Mov Disord. 2010 Aug 15;25(11):1670-4.","DOI":"10.1002\/mds.23148"},{"key":"6152_CR135","doi-asserted-by":"crossref","unstructured":"136. Wojciechowska O, Kujawska M. Urolithin A in Health and Diseases: Prospects for Parkinson\u2019s Disease Management. Antioxidants (Basel). 2023 Jul 24;12(7):1479.","DOI":"10.3390\/antiox12071479"},{"issue":"12","key":"6152_CR136","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1002\/mds.28788","volume":"36","author":"SJG Veenhuis","year":"2021","unstructured":"Veenhuis SJG, van Os NJH, Janssen AJWM, van Gerven MHJC, Coene KLM, Engelke UFH, Wevers RA, Tinnevelt GH, Ter Heine R, van de Warrenburg BPC, Weemaes CMR, Roeleveld N, Willemsen MAAP (2021) Nicotinamide riboside improves ataxia scores and immunoglobulin levels in ataxia telangiectasia. Mov Disord 36(12):2951\u20132957","journal-title":"Mov Disord"},{"issue":"4","key":"6152_CR137","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s11010-023-04771-7","volume":"479","author":"M Alrouji","year":"2024","unstructured":"Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Ashour NA, Jabir MS, Negm WA, Batiha GE (2024) Metformin role in Parkinson\u2019s disease: a double-sword effect. Mol Cell Biochem 479(4):975\u2013991","journal-title":"Mol Cell Biochem"},{"key":"6152_CR138","doi-asserted-by":"crossref","unstructured":"139. Liu T, Wu H, Wei J. Molecular insights into Parkinson\u2019s disease and type 2 diabetes mellitus: Metformin\u2019s role and genetic pathways explored. Experimental neurology. 2025 Jan 10;385:115137.","DOI":"10.1016\/j.expneurol.2025.115137"},{"issue":"2","key":"6152_CR139","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1007\/s12035-024-04357-4","volume":"62","author":"S K Soman","year":"2025","unstructured":"K Soman S, Swain M, Dagda RK (2025) BDNF-TrkB signaling in mitochondria: implications for neurodegenerative diseases. Mol Neurobiol 62(2):1756\u20131769","journal-title":"Mol Neurobiol"},{"key":"6152_CR140","doi-asserted-by":"crossref","unstructured":"141. Uittenbogaard M, Brantner CA, Chiaramello A. Epigenetic modifiers promote mitochondrial biogenesis and oxidative metabolism leading to enhanced differentiation of neuroprogenitor cells. Cell Death Dis. 2018 Mar 2;9(3):360.","DOI":"10.1038\/s41419-018-0396-1"},{"key":"6152_CR141","doi-asserted-by":"crossref","unstructured":"142. Kochan SMV, Malo MC, Jevtic M, Jahn-Kelleter HM, Wani GA, Ndoci K, P\u00e9rez-Revuelta L, Gaedke F, Sch\u00e4ffner I, Lie DC, Schauss A, Bergami M. Enhanced mitochondrial fusion during a critical period of synaptic plasticity in adult-born neurons. Neuron. 2024 Jun 19;112(12):1997\u20132014.e6.","DOI":"10.1016\/j.neuron.2024.03.013"},{"issue":"1","key":"6152_CR142","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","volume":"318","author":"A Schober","year":"2004","unstructured":"Schober A (2004) Classic toxin-induced animal models of Parkinson\u2019s disease: 6-OHDA and MPTP. Cell Tissue Res 318(1):215\u201324","journal-title":"Cell Tissue Res"},{"issue":"9","key":"6152_CR143","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrn.2017.75","volume":"18","author":"JB Koprich","year":"2017","unstructured":"Koprich JB, Kalia LV, Brotchie JM (2017) Animal models of \u03b1-synucleinopathy for Parkinson disease drug development. Nat Rev Neurosci 18(9):515\u2013529","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"6152_CR144","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.lfs.2019.03.057","volume":"226","author":"C Raza","year":"2019","unstructured":"Raza C, Anjum R, Shakeel NUA (2019) Parkinson\u2019s disease: mechanisms, translational models and management strategies. Life Sci 226(1):77\u201390","journal-title":"Life Sci"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-026-06152-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06152-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-026-06152-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T17:03:47Z","timestamp":1774371827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-026-06152-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":144,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6152"],"URL":"https:\/\/doi.org\/10.1007\/s00018-026-06152-x","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical statement"}},{"value":"The authors declare that there is no conflict of interest regarding the publication of this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}}],"article-number":"175"}}